• Michail Kornaropoulos, Demetrios Moris, Eliza W Beal, Marinos C Makris, Apostolos Mitrousias, Athanasios Petrou, Evangelos Felekouras, Adamantios Michalinos, Michail Vailas, Dimitrios Schizas, and Alexandros Papalampros.
• 1st Department of Surgery, "G. Genimatas" General Hospital, Athens, Greece.
• Surg Endosc. 2017 Nov 1; 31 (11): 4382-4392.

BackgroundPancreaticoduodenectomy (PD) is a complex operation with high perioperative morbidity and mortality, even in the highest volume centers. Since the development of the robotic platform, the number of reports on robotic-assisted pancreatic surgery has been on the rise. This article reviews the current state of completely robotic PD.Materials And MethodsA systematic literature search was performed including studies published between January 2000 and July 2016 reporting PDs in which all procedural steps (dissection, resection and reconstruction) were performed robotically.ResultsThirteen studies met the inclusion criteria, including a total of 738 patients. Data regarding perioperative outcomes such as operative time, blood loss, mortality, morbidity, conversion and oncologic outcomes were analyzed. No major differences were observed in mortality, morbidity and oncologic parameters, between robotic and non-robotic approaches. However, operative time was longer in robotic PD, whereas the estimated blood loss was lower. The conversion rate to laparotomy was 6.5-7.8%.ConclusionsRobotic PD is feasible and safe in high-volume institutions, where surgeons are experienced and medical staff are appropriately trained. Randomized controlled trials are required to further investigate outcomes of robotic PD. Additionally, cost analysis and data on long-term oncologic outcomes are needed to evaluate cost-effectiveness of the robotic approach in comparison with the open technique.

23 keywords...

hide…